EdgeMarketInstruments › SVRA

SVRA — Savara Inc

US Healthcare Pharma & biotech equity mkt cap 1.1B
5.59 +1.82% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 3.05 · high 6.94

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+1.82%
1 week+3.90%
1 month-2.78%
3 months+10.47%
6 months+1.08%
Year to date-0.89%
1 year+80.91%
3 years+57.46%
5 years+369.75%

Technicals

RSI 1457.1
vs 50-day avg-1.35%
vs 200-day avg+1.30%
Volatility 1y54.0%
Max drawdown 1y-31.99%
Avg volume 30d1.7M
Daily bars held2,674
History from2016-01-04

Measured signals that fired on SVRA

datesignal measured base rate
2026-07-01Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-05-15Institutional holders jumped in a quarter
ownership
-0.52% over 21 days · t = -0.38 · n = 1,553
not distinguishable from its control group
2026-03-17Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-07-15Lutz Robert Matthew
Chief Fin. & Operating Officer
Grant or award35.0K0.000
2026-06-22Lowrance David L
Chief Financial Officer
Open-market sale394.5K5.682.2M
2026-06-22Lowrance David L
Chief Financial Officer
Shares withheld for tax60.1K5.50330.3K
2026-06-22Lowrance David L
Chief Financial Officer
Option exercise218.8K1.51330.3K
2026-06-22Lowrance David L
Chief Financial Officer
Shares withheld for tax53.4K5.50293.6K
2026-06-22Lowrance David L
Chief Financial Officer
Option exercise87.7K3.35293.6K
2026-06-22Lowrance David L
Chief Financial Officer
Shares withheld for tax28.9K5.50159.1K
2026-06-22Lowrance David L
Chief Financial Officer
Option exercise129.3K1.23159.1K
2026-06-22Lowrance David L
Chief Financial Officer
Shares withheld for tax21.7K5.50119.3K
2026-06-22Lowrance David L
Chief Financial Officer
Option exercise75.0K1.59119.2K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
NEA Management Company, LLC133.6M24.5M
Bain Capital Life Sciences Investors, LLC96.1M17.6M
Venrock Adviser, LLC75.0M13.7M
DEERFIELD MANAGEMENT COMPANY, L.P.74.1M13.6M
TCG Crossover Management, LLC67.5M12.4M
BlackRock, Inc.61.6M11.3M
Frazier Life Sciences Management, L.P.53.1M9.7M
Polar Capital Holdings Plc52.1M9.5M
VANGUARD CAPITAL MANAGEMENT LLC42.5M7.8M
Nantahala Capital Management, LLC40.1M7.3M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
S-82026-08-11on EDGAR ↗
10-Q2026-08-112026-06-30on EDGAR ↗
42026-07-242026-07-15on EDGAR ↗
42026-06-222026-06-22on EDGAR ↗
1442026-06-22on EDGAR ↗
8-K2026-06-082026-06-04on EDGAR ↗
10-Q2026-05-122026-03-31on EDGAR ↗
ARS2026-04-242025-12-31on EDGAR ↗

Short selling

Avg short volume, 90d72.1% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about SVRA

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open SVRA in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →